April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Diagnosis, Treatment, And Outcomes Of Patients With Infectious Scleritis
Author Affiliations & Notes
  • Kelly L. Hodson
    Ophthalmology, Bascom Palmer Eye Institute, Miami, Florida
  • Anat Galor
    Ophthalmology, Bascom Palmer Eye Institute, Miami, Florida
  • Carol L. Karp
    Ophthalmology, Bascom Palmer Eye Institute, Miami, Florida
  • Thomas A. Albini
    Ophthalmology, Bascom Palmer Eye Institute, Miami, Florida
  • Victor L. Perez
    Ophthalmology, Bascom Palmer Eye Institute, Miami, Florida
  • Janet L. Davis
    Ophthalmology, Bascom Palmer Eye Institute, Miami, Florida
  • Darlene Miller
    Ophthalmology, Bascom Palmer Eye Institute, Miami, Florida
  • Richard K. Forster
    Ophthalmology, Bascom Palmer Eye Institute, Miami, Florida
  • Footnotes
    Commercial Relationships  Kelly L. Hodson, None; Anat Galor, None; Carol L. Karp, None; Thomas A. Albini, None; Victor L. Perez, None; Janet L. Davis, None; Darlene Miller, None; Richard K. Forster, None
  • Footnotes
    Support  Unrestricted Grant for Research to Prevent Blindness
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 5861. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Kelly L. Hodson, Anat Galor, Carol L. Karp, Thomas A. Albini, Victor L. Perez, Janet L. Davis, Darlene Miller, Richard K. Forster; Diagnosis, Treatment, And Outcomes Of Patients With Infectious Scleritis. Invest. Ophthalmol. Vis. Sci. 2011;52(14):5861.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To evaluate the inciting factors, diagnostic accuracy, causative organisms, and treatment outcomes of patients with infectious scleritis.

Results: : The authors present a series of 53 patients (55 eyes) whom were diagnosed with infectious scleritis at Bascom Palmer Eye Institute. The median age at presentation was 70 years (range 34-92). An inciting factor (including prior ocular surgery and history of trauma) could be identified in 91% of patients. The median time from identified inciting event to the occurrence of infectious scleritis was 2.4 months, with a range from 0 to 134 months. Forty-four percent of eyes were initially treated with immunosuppressive therapy (43% with local corticosteroids and 15% with systemic corticosteroids) prior to the diagnosis of infectious scleritis. A concomitant corneal or intraocular infection was identified in 18 patients. Of 55 cases of infectious scleritis, 86% were due to bacterial species while 13% were due to fungi. Medical treatment was utilized in almost all patients in the form of topical antimicrobials (95%), oral antimicrobials (78%), and intravitreal antimicrobials (11%). In addition, 44 cases required 1 or more acute surgical procedures to eradicate the infection, with 12 patients requiring enucleation. The median time to resolution of infection was 49 days (range 0 to 378 days). The time to resolution was not significantly different between eyes with a bacterial versus fungal etiology, a delay versus an immediate diagnosis of infection scleritis, or medical treatment alone versus medical treatment with adjuvant surgical intervention. Approximately 50% of patients maintained 20/200 or better visual acuity in the eye affected with scleritis over the course of their treatment and follow up.

Conclusions: : Infectious scleritis can occur days to years after ocular surgery. While intensive medical and surgical treatment can eradicate the disease in most patients, the visual prognosis is guarded due to the development of multiple concomitant ocular complications.

Keywords: sclera • microbial pathogenesis: clinical studies • bacterial disease 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×